Modulation of mouse macrophage polarization in vitro using IL-4 delivery by osmotic pumps

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 4, 2015, Pages 1339-1345

  Pajarinen, Jukka ^a   Tamaki, Yasunobu ^b   Antonios, Joseph K ^a   Lin, Tzu Hua ^a   Sato, Taishi ^a   Yao, Zhenyu ^a   Takagi, Michiaki ^b   Konttinen, Yrjö T ^c   Goodman, Stuart B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YAMAGATA UNIVERSITY   (Japan)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Inflammation; Interleukin 4; Macrophage polarization; Osmotic pumps; Osteolysis; Total joint replacement

Indexed keywords

ARTHROPLASTY; BIOACTIVITY; DRUG DELIVERY; JOINT PROSTHESES; MAMMALS; MODULATION; OSMOSIS; PATHOLOGY; POLARIZATION; PUMPS;

INFLAMMATION; INTERLEUKIN-4; OSMOTIC PUMPS; OSTEOLYSIS; TOTAL JOINT REPLACEMENT;

MACROPHAGES;

CXCL9 CHEMOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CONDITIONED MEDIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL POLARITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW RATE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; OSTEOLYSIS; PHENOTYPE; REGULATORY MECHANISM; UPREGULATION; ANIMAL; C57BL MOUSE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; OSMOSIS; PHARMACOLOGY;

ANIMALS; BONE MARROW CELLS; CELL POLARITY; CULTURE MEDIA, CONDITIONED; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE, INBRED C57BL; OSMOSIS; PHENOTYPE;

EID: 84923540346     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35278     Document Type: Article

References (28)

1. Gallo J, Goodman SB, Konttinen YT, Raska M. Particle disease: Biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun 2013;19:213-224.
2. Goodman SB, Gibon E, Yao Z. The basic science of periprosthetic osteolysis. Instr Course Lect 2013;62:201-206.
3. Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials 2005;26:1271-1286.
4. Nich C, Takakubo Y, Pajarinen J, Ainola M, Salem A, Sillat T, Rao AJ, Raska M, Tamaki Y, Takagi M, Konttinen YT, Goodman SB, Gallo J. Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res A 2013;101:3033-3045.
5. Goodman SB, Gibon E, Pajarinen J, Lin TH, Keeney M, Ren PG, Nich C, Yao Z, Egashira K, Yang F, Konttinen YT. Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement. J R Soc Interface R Soc 2014;11:20130962.
6. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-969.
7. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011;12:1035-1044.
8. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-737.
9. Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 2012;122:787-795.
10. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-686.
11. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nat Rev Immunol 2011;11:750-761.
12. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011;12:231-238.
13. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009;27:451-483.
14. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010;11:936-944.
15. Trindade MC, Nakashima Y, Lind M, Sun DH, Goodman SB, Maloney WJ, Schurman DJ, Smith RL. Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro. J Orthop Res 1999;17:797-802.
16. Im GI, Han JD. Suppressive effects of interleukin-4 and interleukin-10 on the production of proinflammatory cytokines induced by titanium-alloy particles. J Biomed Mater Res 2001;58:531-536.
17. Rao AJ, Gibon E, Ma T, Yao Z, Smith RL, Goodman SB. Revision joint replacement, wear particles, and macrophage polarization. Acta Biomater 2012;8:2815-2823.
18. Pajarinen J, Kouri VP, Jamsen E, Li TF, Mandelin J, Konttinen YT. The response of macrophages to titanium particles is determined by macrophage polarization. Acta Biomater 2013;9:9229-9240.
19. Rao AJ, Nich C, Dhulipala LS, Gibon E, Valladares R, Zwingenberger S, Smith RL, Goodman SB. Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium. J Biomed Mater Res A 2013;101:1926-1934.
20. Wang Y, Wu NN, Mou YQ, Chen L, Deng ZL. Inhibitory effects of recombinant IL-4 and recombinant IL-13 on UHMWPE-induced bone destruction in the murine air pouch model. J Surg Res 2013;180:e73-e81.
21. Brown BN, Ratner BD, Goodman SB, Amar S, Badylak SF. Macrophage polarization: An opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 2012;33:3792-3802.
22. Gibon E, Ma T, Ren PG, Fritton K, Biswal S, Yao Z, et al. Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles. J Orthop Res 2012;30:547-553.
23. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): Isolation and applications. CSH protocols. 2008;2008:pdb prot5080.
24. Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, Thomas B, Fabbri M, Crawshaw A, Ho LP, Ten Hacken NH, Cobos Jiménez V, Kootstra NA, Hamann J, Greaves DR, Locati M, Mantovani A, Gordon S. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013;121:e57-e69.
25. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
26. Schwarz EM, Campbell D, Totterman S, Boyd A, O'Keefe RJ, Looney RJ. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: A 1-year clinical pilot of etanercept vs. placebo. J Orthop Res 2003;21:1049-1055.
27. Antonios JK, Yao Z, Li C, Rao AJ, Goodman SB. Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol 2013;10:471-482.
28. Ma T, Huang Z, Ren PG, McCally R, Lindsey D, Smith RL, et al. An in vivo murine model of continuous intramedullary infusion of polyethylene particles. Biomaterials 2008;29:3738-3742.